KLK3 and prostate carcinoma: LE panellists discussed personal experiences of DRE and questioned the benefits of the test in detecting prostate cancer over PSA and MRI; they referred to cases where men have ‘a positive PSA and MRI, but no detectable cancer on DRE’.